PPAR-γ agonist pioglitazone protects against IL-17 induced intervertebral disc inflammation and degeneration via suppression of NF-κB signaling pathway.

Liu, Yi; Qu, Yuan; Liu, Lian; Zhao, Hua; Ma, Hecheng; Si, Meng; Cheng, Lei; Nie, Lin.
Int Immunopharmacol; 72: 138-147, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30981079